drug
BBO-8520
Phase 1updated 5mo agoby $BBOT BridgeBio Oncology Therapeutics, Inc.
Phase 1community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying BBO-8520
News(1)
- Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra useKaryopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup…biopharma_dive · 22d ago
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that